Cervical cancer vaccine may get OK
FDA panel also to decide if young girls to have shots
WASHINGTON -- Federal advisers are expected to recommend today whether the Food and Drug Administration should approve a vaccine against a sexually transmitted virus that causes cervical cancer, and whether it should be given to girls as young as 9 years old. (Full article: 795 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
Waiting for Twitter to feed in the latest...